Cala Health is a bioelectronic medicine company, headquartered in San Francisco Bay Area, California. Cala Health is transforming the standard of care for chronic disease. The company’s wearable neuromodulation therapies merge innovations in neuroscience and technology to deliver individualized peripheral nerve stimulation. The first indication for Cala Health’s wearable therapy is essential tremor, a disease experienced by more than seven million people and characterized by severe hand tremors. New therapies are under development in neurology, cardiology, and psychiatry.
Cala Health is partnering with the Goldstein Lab (CNL-SD) and Dr Napadow on RAVANS studies.
More information on Cala Health here.